Sunday, 21st November ESA-SRB-ANZBMS 2021

1:30PM        Richard Prince
Update from the ANZBMS therapeutics committee

• Fibrodysplasia Ossificans Progressiva: Insights Into Heterotopic Bone Formation From a Rare Congenital Bone Disorder - Roderick Clifton-Bligh
• The Role of Bisphosphonates in the Management of Bone Health Issues in Childhood. - Peter J Simm
• Osteoanabolic Therapy: A New Era for Osteoporosis?  - Weiwen Chen

The conference acknowledges the support of:

• The gut microbiome and bone metabolism: an update. - Marlena C Kruger

• High-intensity exercise and hip bone geometry in postmenopausal women on or off bone medication: The MEDEX-OP trial - Melanie Kistler-Fischbacher
• Creatinine to cystatin C ratio: A novel biomarker of sarcopenia measures and falls risk in community-dwelling older women? - Marc Sim
• Associations between Vitamin D Receptor polymorphism, Childhood Fracture Risk and Maternal Vitamin D Levels in utero: The Vitamin D in Pregnancy Study - Mia A Percival
• Bisphosphonates and bone mineral density in patients on haemodialysis and renal transplant: a 15-year single-centre experience - Dominic Hauck
• Kinetic reconstruction of the cancellous (Cn) and endocortical (Ec) remodeling unit reveals a net positive bone balance after 12 months (M12) of treatment with romosozumab (Romo) - Erik F Eriksen

5:45 PM Panel Discussion

The conference acknowledges the support of:

• Discovery to Industry - Jeremy Thompson
• Discovery to Policy - John Newnham
• Discovery to the Clinic - Helena Teede

https://spatial.chat/s/esasrbanzbms2021

Prof Bu Yeap
ESA President

Prof Moira O’Bryan
SRB President

Prof Natalie Sims
ANZBMS President

The conference acknowledges the support of:

https://spatial.chat/s/esasrbanzbms2021

The conference acknowledges the support of: